Literature DB >> 22433774

Patient access to new cancer drugs in the United States and Australia.

Michael Wonder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22433774     DOI： 10.1016/j.jval.2011.10.012

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Comparing subsidized access to medicines across payer systems.

Authors:  Michael Wonder; Richard Milne
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

Review 2.  Immuno-Oncology Medicines: Policy Implications and Economic Considerations.

Authors:  Georges Adunlin; Stefanie P Ferreri; Jenny Dong; Maisha Kelly Freeman
Journal:  Innov Pharm       Date:  2019-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.